In breast and non-small cell lung carcinomas, the Hsp70 positivity of the blood was associated with higher tumor stages and an increased risk for developing metastases (Rothammer et al. 2019; Gunther et al. 2015). Here, HSPA1A is linked to non-small cell lung carcinoma.